<DOC>
	<DOCNO>NCT00242541</DOCNO>
	<brief_summary>The purpose study evaluate efficacy octreotide acetate decrease GH IGF-I level acromegalic patient , microadenomas ( â‰¤ 10 mm ) macroadenomas ( &gt; 10 mm ) .</brief_summary>
	<brief_title>Study Assessing Efficacy Safety Octreotide Acetate Patients With Acromegaly , With Micro Macroadenomas</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Male female patient age 18 80 year . Newly diagnose previously treat acromegalic patient . Lack suppression GH nadir &lt; 1.0 microg/L , oral administration 75 g glucose ( OGTT ) . IGFI level upper limit normal , i.e . 97th percentile ( adjust age gender ) . Requires surgery recent significant deterioration visual field neurological sign , relate pituitary tumor mass . No evidence pituitary adenoma Magnetic Resonance Imaging ( MRI ) . Symptomatic cholelithiasis . Unstable angina , sustain ventricular tachycardia , ventricular fibrillation , history acute myocardial infarction within three month precede study entry . Liver disease cirrhosis , chronic active hepatitis chronic persistent hepatitis , persistent ALT , AST , alkaline phosphatase 2 x &gt; upper limit normal , total bilirubin 1.5 x &gt; upper limit normal . Female patient pregnant lactating , childbearing potential practicing medically acceptable method birth control . Medically acceptable method include oral birth control pill , intrauterine device , mechanical method ( e.g . vaginal diaphragm , vaginal sponge condom spermicidal jelly ) . If oral contraception use , patient must practice method least two month prior screen visit must agree continue oral contraceptive throughout course study , one month study end . History immunocompromise , include positive HIV test result ( ELISA Western blot ) . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>microadenoma</keyword>
	<keyword>macroadenoma</keyword>
</DOC>